glp-1 news today september 2025 8, 2025: FDA launches an import alert listing safe manufacturers – Partnership for Safe Medicines Study sets new benchmark for

Glucagon-like peptide-1 receptor agonist (GLP-1RAs) and more recently Twin-Cretins (GLP+GIP) are frequently used for patients with diabetes and associated obesity

This article explores the science behind these agents.

These assets aim to move beyond the current weekly injection paradigm, signalling a future where extended dosing intervals could become central to maintenance strategies [16].

Emerging applications include non-alcoholic fatty liver disease and neurodegenerative conditions

Each serving delivers 78 billion CFUs from a broad range of beneficial strains including Lactobacillus, Bifidobacterium, Akkermansia muciniphila and Christensenella minuta, known for their contribution to a balanced gut microbiome

However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety